Nitric oxide as a regulator in preimplantation embryo development and apoptosis

Huei Wen Chen, Wen Sheng Jiang, Chii Ruey Tzeng

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Objective: To investigate the mechanisms of nitric oxide (NO) in the development and apoptosis of preimplantation mouse embryos. Design: Prospective, controlled study. Setting: Medical college laboratory. Subject(s): Two-cell embryos from outbred ICR mice. Intervention(s): Hyperstimulation protocol, two-cell embryos were collected, then treated with or without an NO synthase inhibitor (L-NAME) or an NO donor (SNP) and combined with a cGMP analogue (8-Br-cGMP) or a selective inhibitor of NO-sensitive soluble guanylyl cyclase (ODQ). Main Outcome Measure(s): The development of ICR mouse embryo from two cells to blastocyst stages in vitro. Result(s): The development of blastocyst was inhibited by L-NAME in a concentration-dependent manner (0.1-10 μM) and 0.1 μM SNP reversed this effect (80.5% of control). Annexin-V/propidium iodide and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling techniques demonstrated that excessive NO (≥10 μM) might induce apoptosis in the mouse embryos. 8-Br-cGMP reversed the inhibitory effect of L-NAME and rescued the embryo growth. ODQ inhibited the embryo development in a dose-responsive fashion (0.1-100 μM) but had no effect in the NO-induced embryo apoptosis. P53 and Bax were found to be up-regulated during the embryo fragmentation. Conclusion(s): These results indicate that the cGMP pathway might be involved in the NO-regulated embryonic development, but not in NO-induced apoptosis, for which P53/Bax pathway might be involved.

Original languageEnglish
Pages (from-to)1163-1171
Number of pages9
JournalFertility and Sterility
Volume75
Issue number6
DOIs
Publication statusPublished - 2001

Fingerprint

Embryonic Development
Nitric Oxide
Embryonic Structures
Apoptosis
NG-Nitroarginine Methyl Ester
Blastocyst
Inbred ICR Mouse
Single Nucleotide Polymorphism
Nitric Oxide Donors
DNA Nucleotidylexotransferase
Propidium
Annexin A5
Nitric Oxide Synthase
Outcome Assessment (Health Care)
Prospective Studies
Growth

Keywords

  • Apoptosis
  • c-GMP
  • Embryo development
  • Nitric oxide
  • p53

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Nitric oxide as a regulator in preimplantation embryo development and apoptosis. / Chen, Huei Wen; Jiang, Wen Sheng; Tzeng, Chii Ruey.

In: Fertility and Sterility, Vol. 75, No. 6, 2001, p. 1163-1171.

Research output: Contribution to journalArticle

Chen, Huei Wen ; Jiang, Wen Sheng ; Tzeng, Chii Ruey. / Nitric oxide as a regulator in preimplantation embryo development and apoptosis. In: Fertility and Sterility. 2001 ; Vol. 75, No. 6. pp. 1163-1171.
@article{ba5919fd7f1d41ddab2f22fb81bf94fa,
title = "Nitric oxide as a regulator in preimplantation embryo development and apoptosis",
abstract = "Objective: To investigate the mechanisms of nitric oxide (NO) in the development and apoptosis of preimplantation mouse embryos. Design: Prospective, controlled study. Setting: Medical college laboratory. Subject(s): Two-cell embryos from outbred ICR mice. Intervention(s): Hyperstimulation protocol, two-cell embryos were collected, then treated with or without an NO synthase inhibitor (L-NAME) or an NO donor (SNP) and combined with a cGMP analogue (8-Br-cGMP) or a selective inhibitor of NO-sensitive soluble guanylyl cyclase (ODQ). Main Outcome Measure(s): The development of ICR mouse embryo from two cells to blastocyst stages in vitro. Result(s): The development of blastocyst was inhibited by L-NAME in a concentration-dependent manner (0.1-10 μM) and 0.1 μM SNP reversed this effect (80.5{\%} of control). Annexin-V/propidium iodide and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling techniques demonstrated that excessive NO (≥10 μM) might induce apoptosis in the mouse embryos. 8-Br-cGMP reversed the inhibitory effect of L-NAME and rescued the embryo growth. ODQ inhibited the embryo development in a dose-responsive fashion (0.1-100 μM) but had no effect in the NO-induced embryo apoptosis. P53 and Bax were found to be up-regulated during the embryo fragmentation. Conclusion(s): These results indicate that the cGMP pathway might be involved in the NO-regulated embryonic development, but not in NO-induced apoptosis, for which P53/Bax pathway might be involved.",
keywords = "Apoptosis, c-GMP, Embryo development, Nitric oxide, p53",
author = "Chen, {Huei Wen} and Jiang, {Wen Sheng} and Tzeng, {Chii Ruey}",
year = "2001",
doi = "10.1016/S0015-0282(01)01780-0",
language = "English",
volume = "75",
pages = "1163--1171",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Nitric oxide as a regulator in preimplantation embryo development and apoptosis

AU - Chen, Huei Wen

AU - Jiang, Wen Sheng

AU - Tzeng, Chii Ruey

PY - 2001

Y1 - 2001

N2 - Objective: To investigate the mechanisms of nitric oxide (NO) in the development and apoptosis of preimplantation mouse embryos. Design: Prospective, controlled study. Setting: Medical college laboratory. Subject(s): Two-cell embryos from outbred ICR mice. Intervention(s): Hyperstimulation protocol, two-cell embryos were collected, then treated with or without an NO synthase inhibitor (L-NAME) or an NO donor (SNP) and combined with a cGMP analogue (8-Br-cGMP) or a selective inhibitor of NO-sensitive soluble guanylyl cyclase (ODQ). Main Outcome Measure(s): The development of ICR mouse embryo from two cells to blastocyst stages in vitro. Result(s): The development of blastocyst was inhibited by L-NAME in a concentration-dependent manner (0.1-10 μM) and 0.1 μM SNP reversed this effect (80.5% of control). Annexin-V/propidium iodide and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling techniques demonstrated that excessive NO (≥10 μM) might induce apoptosis in the mouse embryos. 8-Br-cGMP reversed the inhibitory effect of L-NAME and rescued the embryo growth. ODQ inhibited the embryo development in a dose-responsive fashion (0.1-100 μM) but had no effect in the NO-induced embryo apoptosis. P53 and Bax were found to be up-regulated during the embryo fragmentation. Conclusion(s): These results indicate that the cGMP pathway might be involved in the NO-regulated embryonic development, but not in NO-induced apoptosis, for which P53/Bax pathway might be involved.

AB - Objective: To investigate the mechanisms of nitric oxide (NO) in the development and apoptosis of preimplantation mouse embryos. Design: Prospective, controlled study. Setting: Medical college laboratory. Subject(s): Two-cell embryos from outbred ICR mice. Intervention(s): Hyperstimulation protocol, two-cell embryos were collected, then treated with or without an NO synthase inhibitor (L-NAME) or an NO donor (SNP) and combined with a cGMP analogue (8-Br-cGMP) or a selective inhibitor of NO-sensitive soluble guanylyl cyclase (ODQ). Main Outcome Measure(s): The development of ICR mouse embryo from two cells to blastocyst stages in vitro. Result(s): The development of blastocyst was inhibited by L-NAME in a concentration-dependent manner (0.1-10 μM) and 0.1 μM SNP reversed this effect (80.5% of control). Annexin-V/propidium iodide and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling techniques demonstrated that excessive NO (≥10 μM) might induce apoptosis in the mouse embryos. 8-Br-cGMP reversed the inhibitory effect of L-NAME and rescued the embryo growth. ODQ inhibited the embryo development in a dose-responsive fashion (0.1-100 μM) but had no effect in the NO-induced embryo apoptosis. P53 and Bax were found to be up-regulated during the embryo fragmentation. Conclusion(s): These results indicate that the cGMP pathway might be involved in the NO-regulated embryonic development, but not in NO-induced apoptosis, for which P53/Bax pathway might be involved.

KW - Apoptosis

KW - c-GMP

KW - Embryo development

KW - Nitric oxide

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0035012888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035012888&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(01)01780-0

DO - 10.1016/S0015-0282(01)01780-0

M3 - Article

VL - 75

SP - 1163

EP - 1171

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -